Lawsuit Overview
May 13, 2013 (Shareholders Foundation) - An investor, who currently holds NASDAQ:SPPI shares, filed a lawsuit against directors of Spectrum Pharmaceuticals, Inc. over alleged breaches of fiduciary duties in connection with certain statements made between August 8, 2012, and March 12, 2013 in regards to the drug FUSILEV. The lawsuit by a current investor against directors of Spectrum ...
You must register (for free) or login to view the entire case.